The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.00
Bid: 16.50
Ask: 17.50
Change: -0.50 (-2.86%)
Spread: 1.00 (6.061%)
Open: 17.50
High: 17.50
Low: 17.00
Prev. Close: 17.50
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: STV raises holding in Two Cities Television

Wed, 31st Jan 2024 18:28

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Ethernity Networks Ltd - Israel-based supplier of data processing semiconductor technology for networking appliances - Announces the formal conclusion of the temporary suspension of proceedings process. Anticipates that the court will submit its formal approval of the settlement proposal during the first two weeks of February. Notwithstanding this, it is not considered necessary to seek a further extension to the TSP. Chief Executive David Levi comments: "We are delighted for the company to be able to conclude the TSP process. We exit the TSP on a far stronger financial footing than when we entered, thanks to the encouraging customer contracts and the fundraise we undertook in December.

----------

GreenRoc Mining PLC - UK and Greenland-focused mineral explorer - Announces the successful results of electrochemical battery test work using graphite from its Amitsoq graphite project in southern Greenland, and an update on its processing plant feasibility study. Chief Executive Stefan Bernstein says: "The outcome of this battery test programme is hugely pleasing. This is the first time that graphite material from our Amitsoq project has been tested for its performance within an assembled lithium ion battery cell. These results demonstrate that uncoated purified spherical graphite from Amitsoq performs very well as the active anode material in a battery cell, which is excellent news." Company says that the first and second work phases of the feasibility study are now complete. The next stages of the feasibility study include the design of both a pilot and full-scale processing plant, estimation of production rates, energy requirements and consumables, a full discounted cash flow model for the full-scale processing plant and integrating a risk model.

----------

Somero Enterprises Inc - Fort Myers, Florida-based laser-guided concrete levelling machinery company - Says following good trading and an excellent operational performance in fulfilling customer orders globally during the second half, it expects to report 2023 revenue of USD120.7 million, in line with previous guidance and market expectations. The 2023 revenue expectation reflects the positive impact of the S-22EZ relaunch at full production on trading and a resilient US non-residential construction market. A strong finish to the year was achieved despite ongoing headwinds in the US from concrete supply chain shortages, elevated interest rates and tightened bank lending. In 2024, expects the US market to remain strong, supported by customers reporting high levels of activity and healthy backlogs, continued growth in Europe and Australia, and multiple new product launches. Expects 2024 will be another highly profitable year with healthy cash generation, revenue comparable to 2023, and earnings before interest, tax, depreciation and amortisation that reflects modest incremental investment including the new Belgium service and training centre and the annualized impact of strategic resources added in 2023.

----------

Hummingbird Resources PLC - West Africa-focused and Birmingham, England-based gold producer, developer and explorer - Reports adjusted earnings before interest, tax, depreciation and amortisation in the fourth quarter ending December of USD0.2 million, resulting adjusted Ebitda for 2023 as a whole of USD34.5 million. Yanfolila produced 14,419 ounces of gold in the quarter, with a total of 83,965 oz in 2023, meeting production guidance of 80,000 to 90,000 oz. All in sustaining cost on gold produced at Yanfolila totalled USD1,701 per oz in the quarter, and USD1,361 per oz (in the year compared to USD1,782 per oz in 2022. This met the 2023 AISC guidance of under USD1,500/oz. Group production guidance for 2024 is 165,000 to 200,000 oz at an AISC below USD1,500, which is weighted towards the second half. Expects to spend USD5 million on exploration across both Yanfolila and Kouroussa.

----------

STV Group PLC - Glasgow-based television broadcaster and content producer - Increases its 25% equity stake in the high-end drama production company, Two Cities Television, to a majority holding of 51%. Explains the drama producer has secured revenue of GBP55 million over next 3 years across multiple series. Investment will help underpin Two Cities' growth and strengthen STV Studios' position as leading Nations & Regions producer. STV acquired a minority stake in Two Cities in January 2020, with an option to increase its initial stake to a majority position upon Two Cities becoming profitable.

----------

Botswana Diamonds PLC - Botswana and South Africa-focused diamond explorer - Announces that a consortium including BOD, which is acting as operator with a 30% stake, collectively known as Diamonds of Eswatini Pty Ltd, has been awarded a prospecting license over the diamondiferous Dokowayo kimberlites in Eswatini. Nil consideration was payable by BOD for its 30% interest. The License of just under 4,000 hectares is for an initial period of one year and renewable for a further year. The plan is to undertake an immediate, updated full desktop review and analysis of secondary sources. Following this, bulk sampling of the dumps and kimberlite stockpile is envisaged as the next step forward.

----------

Ariana Resources PLC - mineral exploration and development company with gold mining interests in Turkey, Cyprus and Kosovo - Updates on the 100% owned Asgard Metals Fund, highlighting some of its associated investments. Reports due diligence drilling programme on the Dokwe Gold project in Zimbabwe is ongoing, with the company increasing the current investment in Rockover Holdings to 2.1% by investing a further USD150,000. Highlights increased investment in Panther Metals to circa 5.5%, following an agreement to extend the consulting input of Asgard by a further year to the end of 2024. Notes Pallas Resources agrees an option and joint venture agreement with First Quantum Minerals, whilst securing BHP funding through their Xplor programme.

----------

Destiny Pharma PLC - Brighton, England-based biotechnology company - Announces positive data from a pivotal preclinical safety study of XF-73 Dermal, used for the treatment of antibiotic resistant skin infections associated with open wounds and broken skin. The product was well tolerated with no significant impact on any clinical or safety parameters and had no apparent negative impact on wound healing. Intends initially to progress XF-73 Dermal towards clinical evaluation for the treatment of Diabetic Foot Infections and serious burn wound infections. Further, changes its contract development manufacturing organisation for NTCD-M3 in order to strengthen manufacturing for clinical trial material and improve future commercial supply. These changes mean that the company now expect drug product for the next stage of clinical development to be available in the second half of 2024.

----------

Mobile Streams PLC - London-based mobile content provider - Completes the acquisition of all associated intellectual property for the print and digital operations of Estadio, and Capital Media Group has also transferred and recruited employees to work on the publication. Believes this provides a solid foundation for the relaunch and extension of the brand. Preparations for the launch of the Mexican betting business (in which MOS has a 25% direct shareholding) are well underway and the business is on track to launch early in the second quarter.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
20 May 2022 16:00

UK shareholder meetings calendar - next 7 days

Monday 23 May 
Brewin Dolphin Holdings PLCGM re acquisition by RBC Wealth Management
Digital 9 Infrastructure PLCAGM
Empiric Student Property PLCAGM
TMT Investments PLCAGM
Tuesday 24 May 
4imprint Group PLCAGM
Afentra PLCAGM
Artisanal Spirits Co PLCAGM
Bidstack Group PLCAGM
Epwin Group PLCAGM
FDM Group Holdings PLCAGM
Forterra PLCAGM
Harworth Group PLCAGM
Henderson High Income Trust PLCAGM
Hill & Smith Holdings PLCAGM
Hilton Food Group PLCAGM
Horizonte Minerals PLCAGM
Judges Scientific PLCAGM
Pebble Group PLCAGM
Quarto Group IncAGM
Restaurant Group PLCAGM
Riverstone Energy LtdAGM
Shell PLCAGM
Thungela Resources LtdAGM
Vector Capital PLCAGM
WPP PLCAGM
Wednesday 25 May  
Access Intelligence PLCAGM
Amur Minerals CorpAGM
Aston Martin Lagonda Global Holdings PLCAGM
Bakkavor Group PLCAGM
Bango PLCAGM
Bodycote PLCAGM
Eleco PLCAGM
International Public Partnerships LtdAGM
Intertek Group PLCAGM
M&G PLCAGM
Manx Financial Group PLCAGM
Mortgage Advice Bureau Holdings PLCAGM
Property Franchise Group PLCGM re final 2021 dividend
Regional REIT LtdAGM
Sabre Insurance Group PLCAGM
Trustpilot Group PLCAGM
Tullow Oil PLCAGM
Zenova Group PLCAGM
Zotefoams PLCAGM
Thursday 26 May 
Aminex PLCAGM
Bank of Ireland Group PLCAGM
Belvoir Group PLCAGM
Central Asia Metals PLCAGM
Curtis Banks Group PLCAGM
Diaceutics PLCAGM
Duke Royalty LtdEGM re fundraise
East Star Resources PLCAGM
Energean PLCAGM
Henry Boot PLCAGM
Hochschild Mining PLCAGM
Legal & General Group PLCAGM
National World PLCAGM
Ocean Wilsons Holdings LtdAGM
OnTheMarket PLCGM re cancellation of capital
Prudential PLCAGM
S&U PLCAGM
Staffline Group PLCAGM
Strix Group PLCAGM
WAG Payment Solutions PLCAGM
Yu Group PLCAGM
Friday 27 May 
AG Barr PLCAGM
Big Technologies PLCAGM
Coca-Cola Europacific Partners PLCAGM
Destiny Pharma PLCAGM
Hostmore PLCAGM
Lancashire Holdings LtdAGM
Lekoil LtdEGM re appointment and remuneration of auditors
LSL Property Services PLCAGM
Malin Corp PLCAGM
Old Mutual LtdAGM
Oxford BioMedica PLCAGM
Renewables Infrastructure Group LtdAGM
Spectris PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
12 May 2022 19:45

TRADING UPDATES: Belluscura to raise GBP5 million; React buys

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
3 May 2022 21:55

TRADING UPDATES: Vela, Standard Life Investments up portfolio value

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
3 May 2022 12:16

Destiny Pharma appoints Yuri Martina as chief medical officer

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the appointment of Dr Yuri Martina as its chief medical officer on Tuesday.

Read more
12 Apr 2022 12:42

EARNINGS UPDATES: Parsley Box widens loss; M Winkworth profit doubles

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
5 Apr 2022 16:34

UK earnings, trading statements calendar - next 7 days

Wednesday 6 April  
Applied Graphene Materials PLCHalf Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Hilton Food Group PLCFull Year Results
Hyve Group PLCTrading Statement
Topps Tiles PLCTrading Statement
Wentworth Resources PLCFull Year Results
Thursday 7 April 
Alpha Financial Markets Consulting PLCTrading Statement
Attraqt Group PLCFull Year Results
Entain PLCQ1 Results
Robert Walters PLCQ1 Results
Tracsis PLCHalf Year Results
Friday 8 April 
CMC Markets PLCTrading Statement
Ferrexpo PLCTrading Statement
Monday 11 April 
Tortilla Mexican Grill PLCFull Year Results
Sirius Real Estate LtdTrading Statement
Tuesday 12 April 
ASOS PLCHalf Year Results
Cambridge Cognition Holdings PLCFull Year Results
Destiny Pharma PLCFull Year Results
easyJet PLCTrading Statement
Filta Group Holdings PLCFull Year Results
JD Sports Fashion PLCFull Year Results
Liontrust Asset ManagementTrading Statement
M Winkworth PLCFull Year Results
Moneysupermarket.com Group PLCTrading Statement
Nanoco Group PLCHalf Year Results
Pennon Group PLCTrading Statement
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
25 Mar 2022 14:26

IN BRIEF: Destiny Pharma raises GBP450,000 through open offer

Destiny Pharma PLC - a clinical-stage biotechnology company based in Brighton, England - Raises total gross proceeds of GBP450,000 through its open offer. Has conditionally raised total gross proceeds of GBP6.5 million through its placing, subscription, and open offer. Says it has applied for the admission of 12.9 million shares, consisting of 11.9 million placing shares, 140,000 subscription shares and 909,007 open offer shares.

Read more
8 Mar 2022 19:38

IN BRIEF: Destiny Pharma to raise GBP7.0 million for asset trials

Destiny Pharma PLC - clinical-stage biotechnology company based in Brighton, England - Intends to raise GBP7.0 million through a placing of 11.9 million shares at 50 pence each, subscription for 140,000 shares and an open offer for 2.0 million shares.

Read more
8 Mar 2022 13:55

Destiny Pharma to raise up to £7m in discounted fundraising

(Sharecast News) - Clinical stage biotechnology company Destiny Pharma said on Tuesday that it was looking to raise up to £7m in a conditional fundraising to continue progress towards Phase 3 in its two lead clinical assets.

Read more
8 Feb 2022 20:36

IN BRIEF: Destiny Pharma receives Europe watchdog XF-73 boost

IN BRIEF: Destiny Pharma receives Europe watchdog XF-73 boost

Read more
8 Feb 2022 15:07

Destiny upbeat on nasal gel feedback from EMA

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma said on Tuesday that it has received positive scientific advice from the European Medicines Agency (EMA), following its review of its proposed phase 3 clinical programme design.

Read more
1 Feb 2022 14:57

Destiny successfully completes preclinical study of dermal formulation

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the successful completion of a preclinical safety study with a novel 'XF-73' dermal formulation on Tuesday.

Read more
24 Jan 2022 13:44

Destiny Pharma reports success in US C. diff trial

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the successful outcome of its cooperative research and development agreement with the US Department of Veterans Affairs (VA) on Monday.

Read more
21 Jan 2022 14:36

IN BRIEF: Destiny Pharma notes study that shows need for XF platform

IN BRIEF: Destiny Pharma notes study that shows need for XF platform

Read more
17 Jan 2022 18:40

TRADING UPDATES: MP Evans declares special payout as production rises

TRADING UPDATES: MP Evans declares special payout as production rises

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.